Evonik with mixed analyst views, consensus shapes the stock picture
30.06.2026 - 13:06:59 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 13:06.
Evonik Industries (DE000EVNK013) opens Tuesday with a clear analyst backdrop. The shares trade in Frankfurt and Xetra as part of Germany's listed specialty chemicals segment, with recent research updates anchoring the view for retail investors.
What recent research shows
Deutsche Bank Research reiterated its Hold rating on Evonik on June 29 with a price target of 17 euros, keeping a cautious stance on the stock's upside potential relative to current levels. The bank highlights risks in the methionine business, where increasing supply could weigh on earnings expectations beyond 2026.
Jefferies, by contrast, remains constructive on Evonik and has kept a Buy recommendation in place with a 20 euro target in its latest published view, positioning the company as a preferred cyclical exposure among European chemicals names. The differing stances underline that the analyst community remains divided on the medium-term profit trajectory.
The consensus in numbers
Consensus data compiled around June 29 point to an Evonik share price of 15.68 euros, with valuation ratios for 2026 such as a price-earnings multiple near 14.7 times and a price-to-book ratio around 0.88 times for the group. The stock is classified in the specialized chemicals category, and the implied dividend yield of roughly 4.98 percent for the current year looks robust compared with broader European equity benchmarks.
Across the coverage universe, the average price target embedded in consensus stands above the current quotation, implying measured upside if forecasts are met. Buy and Hold ratings dominate the distribution, while clear Sell calls remain in the minority, which is consistent with the neutral to constructive framing of Evonik within the sector.
All news and analysis on the Evonik Industries shares
Further disclosures, prior coverage and detailed price and consensus data on Evonik are available via the ad-hoc-news topic page and the company’s investor relations section.
The business behind the stock
Evonik generates most of its revenue from specialty chemicals used in consumer goods, agriculture and industrial applications, with core lines including additives for plastics, coatings and nutrition. The methionine portfolio for animal feed and high-performance polymers for advanced manufacturing remain central pillars of the business model.
Where the shares trade today
The Evonik Industries shares (DE000EVNK013) last traded on Xetra on 2026-06-29 at 15.68 euros, based on closing data from the German exchange.
Key data on the Evonik Industries shares
- Company: Evonik Industries AG
- ISIN: DE000EVNK013
- WKN: EVNK01
- Ticker: EVK
- Trading venue: Xetra
- Price (as of 2026-06-29, 17:35): 15.68 EUR
- Market cap: around 7.0 billion EUR (as of 2026-06-29)
- Sector / industry: Specialty chemicals
- Index membership: MDAX
- Next earnings date: not officially scheduled
This text is intended solely for informational purposes and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial service. All data were compiled with care but without guarantee for accuracy or completeness.
